Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |